Matsueda, Kei
Fukudo, Shin
Ogishima, Masayuki
Naito, Yuki
Nakamura, Soichiro
Article History
Received: 4 August 2023
Accepted: 24 January 2024
First Online: 8 February 2024
Declarations
:
: The Institutional Review Board at Fukui General Hospital evaluated and approved the protocol (reference number ZO-Y60 20111202). All participants provided written informed consent prior to study participation.
: All authors have given consent for publication.
: Kei MATSUEDA and Shin FUKUDO are contracted medical consultants to Zeria Pharmaceutical Co., Ltd., with institutional approval of COI. Masayuki OGISHIMA, Yuki NAITO and Soichiro NAKAMURA are employees of Zeria Pharmaceutical Co., Ltd.